☰

Shaohua Yu, Ph.D. - Publications

Affiliations: 
2000 State University of New York at Binghamton, Vestal, NY, United States 
Area:
Statistics
Tree Info Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Zuo LJ, Yu SY, Wang F, Hu Y, Piao YS, Du Y, Lian TH, Wang RD, Yu QJ, Wang YJ, Wang XM, Chan P, Chen SD, Wang Y, Zhang W. Parkinson's Disease with Fatigue: Clinical Characteristics and Potential Mechanisms Relevant to α-Synuclein Oligomer. Journal of Clinical Neurology (Seoul, Korea). PMID 26869370  0.461
2015 Yu S, Zhang B, Xiang C, Shu Y, Wu H, Huang X, Yu Q, Yin Y, Guo R. Prospective assessment of pemetrexed or pemetrexed plus platinum in combination with gefitinib or erlotinib in patients with acquired resistance to gefitinib or erlotinib: a phase II exploratory and preliminary study. Clinical Lung Cancer. 16: 121-7. PMID 25450874 DOI: 10.1016/j.cllc.2014.09.007  0.413
2014 Cheung LW, Yu S, Zhang D, Li J, Ng PK, Panupinthu N, Mitra S, Ju Z, Yu Q, Liang H, Hawke DH, Lu Y, Broaddus RR, Mills GB. Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitors. Cancer Cell. 26: 479-94. PMID 25284480 DOI: 10.1016/j.ccell.2014.08.017  0.486
2014 Yu S, Zhang Z, Zhang B, Shu Y, Wu H, Huang X, Yu Q, Guo R. Clinical significance of PIK3CA and survivin in primary adenosquamous lung carcinoma. Medical Oncology (Northwood, London, England). 31: 983. PMID 24838432 DOI: 10.1007/s12032-014-0983-7  0.375
2014 Yu QQ, Wu H, Huang X, Shen H, Shu YQ, Zhang B, Xiang CC, Yu SM, Guo RH, Chen L. MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 68: 155-61. PMID 24486107 DOI: 10.1016/j.biopha.2014.01.005  0.385
2012 Claerhout S, Dutta B, Bossuyt W, Zhang F, Nguyen-Charles C, Dennison JB, Yu Q, Yu S, Balázsi G, Lu Y, Mills GB. Abortive autophagy induces endoplasmic reticulum stress and cell death in cancer cells. Plos One. 7: e39400. PMID 22745748 DOI: 10.1371/Journal.Pone.0039400  0.403
2011 Lu Y, Muller M, Smith D, Dutta B, Komurov K, Iadevaia S, Ruths D, Tseng JT, Yu S, Yu Q, Nakhleh L, Balazsi G, Donnelly J, Schurdak M, Morgan-Lappe S, et al. Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signaling. Oncogene. 30: 4567-77. PMID 21666717 DOI: 10.1038/Onc.2011.164  0.43
2007 Hennessy BT, Lu Y, Poradosu E, Yu Q, Yu S, Hall H, Carey MS, Ravoori M, Gonzalez-Angulo AM, Birch R, Henderson IC, Kundra V, Mills GB. Pharmacodynamic markers of perifosine efficacy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 7421-31. PMID 18094426 DOI: 10.1158/1078-0432.CCR-07-0760  0.468
2004 Kohn EC, Lu Y, Wang H, Yu Q, Yu S, Hall H, Smith DL, Meric-Bernstam F, Hortobagyi GN, Mills GB. Molecular therapeutics: promise and challenges. Seminars in Oncology. 31: 39-53. PMID 15052542 DOI: 10.1053/J.SEMINONCOL.2004.01.009  0.422
Show low-probability matches.